Orthofix Medical
OFIX
145 hedge funds and large institutions have $519M invested in Orthofix Medical in 2020 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 70 increasing their positions, 47 reducing their positions, and 22 closing their positions.
49% more repeat investments, than reductions
Existing positions increased: 70 | Existing positions reduced: 47
0.86% less ownership
Funds ownership: 97.45% → 96.58% (-0.86%)
8% less funds holding
Funds holding: 157 → 145 (-12)
40% less capital invested
Capital invested by funds: $858M → $519M (-$339M)
45% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 22
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SBH
Segall Bryant & Hamill
Chicago,
Illinois
|
+$10M |
| 2 |
Morgan Stanley
New York
|
+$9.02M |
| 3 |
PIM
Paradice Investment Management
Denver,
Colorado
|
+$8.6M |
| 4 |
JP Morgan Chase
New York
|
+$5.87M |
| 5 |
Renaissance Technologies
New York
|
+$3.53M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$16M |
| 2 |
Millennium Management
New York
|
-$11.1M |
| 3 |
RCAMU
Rothschild & Co Asset Management US
Stamford,
Connecticut
|
-$8.93M |
| 4 |
BlackRock
New York
|
-$3.72M |
| 5 |
DGHMC
Dalton, Greiner, Hartman, Maher & Co
New York
|
-$3.72M |
OFIX Hedge Fund Activity: Q1 2020 in Review
145 of the 4,547 institutional investors tracked by Wall St. Rank reported a position in Orthofix Medical (OFIX) for Q1 2020, worth a combined $519M — down 40% from $858M a quarter earlier.
Sellers outnumbered buyers: 22 funds closed out of OFIX and 12 opened new positions — a net loss of 10 holders — while 47 trimmed existing stakes and 70 added.
The largest buyer was Segall Bryant & Hamill, adding an estimated $10M. The largest seller was Goldman Sachs, cutting an estimated $16M.
- 145 institutional investors held Orthofix Medical (OFIX) as of Q1 2020, down from 157 in Q4 2019.
- Funds reported $519M of Orthofix Medical stock for Q1 2020, down 40% quarter-over-quarter.
- 12 funds opened new Orthofix Medical positions in Q1 2020 and 22 closed out, a net change of -10 holders.
- The largest Orthofix Medical buyer in Q1 2020 was Segall Bryant & Hamill, an estimated $10M added.
- The largest Orthofix Medical seller in Q1 2020 was Goldman Sachs, an estimated $16M sold.
Based on aggregated 13F filings for Q1 2020.